University of Nizwa College of Pharmacy and Nursing School of Pharmacy

Slides:



Advertisements
Similar presentations
PHL. 322 Final lab Presented by Mohammed Alyami Teaching assistant Department of pharmacology & Toxicology College of pharmacy KSU.
Advertisements

Drugs Used to Treat Schizophrenia
University Hospital “Sisters of Charity” Psychiatric Clinic Vinogradska c. 29, 1000 Zagreb, Croatia Davor Moravek Addiction and psychotic.
BIPOLAR DISORDER What is Bipolar Disorder? We all experience changes in moods from time to time depending on events we go through in life. But when these.
Schizophrenia. Schizophrenia Psychosis involves loss of contact with reality, symptoms include: 1) Disorganized and deluded thinking 2) Disturbed perceptions.
Early-Onset Psychosis EARLY: Early Assessment and Resource Linkage for Youth May 15, 2008.
Schizoaffective Disorder What is it? How does it affect the person diagnosed? How is it dealt with? What is it? How does it affect the person diagnosed?
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Major Depressive Disorder Presenting Complaints
Psychotic disorders.
Antipsychotic Medications in the Primary Care Practice Angelo Potenciano, M.D.
Schizophrenia Famous schizophrenics: Hölderlin Maupassant Lenz Walser, Robert Proust Strindberg Lenau.
Bipolar I Disorder Treatment. Therapeutic Goals Relief of immediate symptoms Improvement of patient’s well-being Elimination of stressors Combined pharmacotherapy.
OPTIMAL TREATMENT INTERVENTIONS IN RECENT-ONCET PSYCHOSIS Vassilis P. Kontaxakis Associate Professor of Psychiatry, University of Athens.
I CAN Explain psychopharmacology Describe properties, use, and side effects of: Antipsychotic Medications Anti-depressants Anti-anxiety stimulants Copyright.
Pharmacotherapy in Psychotic Disorders. Antipsychotic drugs Treat the symptoms of the disorder Do not cure schizophrenia Include two major classes: –
Schizophrenia Terrence Gault.
Schizophrenia Chapter 14. Louis Wain cat This cat, like many painted during that period, is shown with abstract patterns behind it. Psychologists have.
*a group of severe brain disorders in which people interpret reality abnormally *may result in hallucinations, delusions, and disordered thinking and.
The term schizophrenia comes from two Greek words that mean splitting apart of mental functions. “Split mind“ U-Ajwbok&sns=em.
ANTIPSYCHOTICS Katy and Zoë. Psychosis Mental disorder with a broad range of symptoms. Patients ‘lose touch with reality’ and present with: hallucinations.
Use of Antipsychotic Drugs in Dementia Josepha A. Cheong, MD University of Florida Departments of Psychiatry and Neurology Chief, Division of Geriatric.
Schizophrenia Pathogenesis is unknown. Onset of schizophrenia is in the late teens - early ‘20s. Genetic predisposition -- Familial incidence. Multiple.
By David Gallegos Period 7.  What are the Causes and Symptoms of Schizophrenia ?  How do people who have Schizophrenia live with it and how is it treated?
بسم الله الرحمن الرحيم Dr: Samah Gaafar Hassan Al-shaygi.
Drugs Used for Psychoses Chapter 18 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Schizoaffective, Delusional and Other Psychotic Disorders Chapter 17.
SCHIZOPHRENIA Rogelio Navarro. ESSENTIAL QUESTIONS  What are the different types of schizophrenia and the treatments?  What are the similarities and.
WEEK: SCHIZOPHRENIA. Schizophrenia  Schizophrenia is a chronic psychotic disorder characterized by disturbed behavior, thinking, emotions and perceptions.
Psychosis Madeline Goodman D.O. April 28, Common in both the medical and psychiatric settings Common in both the medical and psychiatric settings.
Personality Disorders. Anti-Social Personality Disorder  A condition characterized by persistent disregard for, and violation of, the rights of others.
BIPOLAR DISORDER, DR GIAN LIPPI CONSULTANT PSYCHIATRIST UNIVERSITY OF PRETORIA & WESKOPPIES HOSPITAL FORENSIC UNIT MANAGEMENT GUIDELINES.
Disability Services.  Severe mental disorders that cause abnormal thinking and perceptions.  The two main symptoms include: delusions and hallucinations.
PSYCHOTIC DISORDER Mental Health First Aid By Mental Health Commission of Canada, 2010.
1. MHFA (Wales) Session 4 (3 hours) What are psychotic disorders (schizophrenia, bipolar disorder)? Symptoms of psychotic disorders. Risk factors for.
Management of Geriatric Psychiatric Disorders Arash Mirabzadeh Psychiatrist University of Social Welfare and Rehabilitation Sciences.
Working with people experiencing psychosis
Schizophrenia: an inside view
Schizophrenia Emmanuel Okenyi.
Overview of Mental Illness
Psychiatric Treatment
Module 3 Indications for Antipsychotics Bipolar Disorder
SESSION 4 Psychosis.
Module 3 Indications Antipsychotics for Schizophrenia
Antipsychotic Agents and Their Use in Schizophrenia
Antipsychotic Prescribing
Antipsychotics academic detailing
Aggressive Patient Assessment and Management
PRESENTED BY Heena Parveen, M.Pharmacy(Pharmacology), CP&PT. PRESENTED BY Heena Parveen, M.Pharmacy(Pharmacology), CP&PT.
PRESENTED BY Heena Parveen, M.Pharmacy(Pharmacology), CP&PT. PRESENTED BY Heena Parveen, M.Pharmacy(Pharmacology), CP&PT.
What is Dementia? A term that describes a wide range of symptoms associated with a decline in memory or other thinking skills. Dementia may be severe.
Antipsychotic Agents and Their Use in Schizophrenia
Clinical pharmacology of antipsychotic agents
Pharmacodynamics: How do antipsychotic medications work?
Clinical Pharmacokinetics
PSYCHOSES.
PHARMACOTHERAPY - I PHCY 310
Schizophrenia Consult
Schizophrenia Spectrum and Other Psychotic Disorders
Schizophrenia Spectrum and Other Psychotic Disorders
Antipsychotics: chemistry and pharmacokinetics
University of Nizwa College of Pharmacy and Nursing School of Pharmacy
Antipsychotic (Neuroleptic) Drugs
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
PHARMACOTHERAPY - I PHCY 310
Anti Psychotic Drugs Biology/Psychology /24/18.
Module 3 Indications for Antipsychotics Bipolar Disorder
Topic Discussion By Alexandria Brown
Describe and Evaluate Biological Treatments for Schizophrenia
Presentation transcript:

University of Nizwa College of Pharmacy and Nursing School of Pharmacy PHARMACOTHERAPY - I PHCY 310 Lecture -12 Psychiatric Disorders “Schizophrenia” Dr. Sabin Thomas, M. Pharm. Ph. D. Assistant Professor in Pharmacy Practice School of Pharmacy University of Nizwa

Course Outcome Upon completion of this lecture the students will be able to Describe pathophysiology, diagnosis, and therapeutic choices including non-pharmacologic and pharmacologic treatments for schizophrenia, Explain the different phases of treatment in schizophrenia.

Pathophysiology Schizophrenia is usually a lifelong psychiatric disability. Psychosis may result from hyper- or hypoactivity of dopaminergic processes in specific brain regions. This may include the presence of a dopamine (DA) receptor defect. Clinical presentation Symptoms of the acute episode may include the following: being out of touch with reality; hallucinations (especially hearing voices); delusions (fixed false beliefs); ideas of influence (actions controlled by external influences); disconnected thought processes (loose associations); ambivalence (contradictory thoughts); flat, inappropriate, or labile affect; autism (withdrawn and inwardly directed thinking); uncooperativeness, hostility, and verbal or physical aggression; impaired self-care skills; and disturbed sleep and appetite.

Psychosis is brain disorder in which there is loss of contact with reality, affecting the ability to think, feel, perceive and act. Investigations 1- History - Withdrawal from usual activities with friends and family - Rapid fluctuations in mood (emotional lability) - Unreasonable suspiciousness - Unusual or bizarre behaviour - Hallucinations - Difficulties in thinking or expressing thoughts 2- Clinical rating scales to monitor the psychotic event - Clinical Global Impression Scales for Severity (CGI-S) - Clinical Global Impression Scales for Change (CGI-C) - Global Assessment of Functioning (GAF)

Therapeutic Choices Nonpharmacologic Choices - Medication adherence - Family psychoeducation - Assessment of postpsychotic depression and suicidality Pharmacologic Choices There are two major classes of antipsychotics: First-generation (typical) antipsychotics (FGAs): e.g., fluphenazine, trifluoperazine, chlorpromazine, haloperidol, and pimozide. Second-generation (atypical) antipsychotics (SGAs): e.g., aripiprazole, clozapine, olanzapine, quetiapine, risperidone, ziprasidone, and paliperidone. Paliperidone is the active metabolite of risperidone, and it is not metabolized by the liver. Therefore it has less drug-drug interactions compared to other antipsychotics.

INITIAL THERAPY The goals during the first 7 days are decreased agitation, hostility, anxiety, and aggression and normalization of sleep and eating patterns. In general, titrate over the first few days to an average effective dose. After 1 week at a stable dose, a modest dosage increase may be considered. If there is no improvement within 3 to 4 weeks at therapeutic doses, then an alternative antipsychotic should be considered. IM antipsychotic administration (e.g., ziprasidone 10 to 20 mg, olanzapine 2.5 to 10 mg, or haloperidol 2 to 5 mg) can be used to calm agitated patients. Intramuscular (IM) lorazepam, 2 mg, as needed in combination with the maintenance antipsychotic may actually be more effective in controlling agitation than using additional doses of the antipsychotic.

STABILIZATION THERAPY During weeks 2 and 3, the goals should be to improve socialization, selfcare habits, and mood. Improvement in formal thought disorder may require an additional 6 to 8 weeks. Most patients require a dose of 300 to 1,000 mg of CPZ equivalents (of FGAs) daily or SGAs in usual labeled doses. Dose titration may continue every 1 to 2 weeks as long as the patient has no side effects. If symptom improvement is not satisfactory after 8 to 12 weeks, a different strategy should be tried.

MAINTENANCE THERAPY Medication should be continued for at least 12 months after remission of the first psychotic episode. Continuous treatment is necessary in most patients at the lowest effective dose. Antipsychotics (especially FGAs and clozapine) should be tapered slowly before discontinuation to avoid rebound cholinergic withdrawal symptoms.